Tickers

1. Composite Trajectory Verdict

Given REZI's capital-intensive manufacturing and distribution model with significant debt-funded strategic transactions, all three statements carry roughly equal weight: the income statement shows operating margin pressure amid revenue growth, the cash flow statement reveals operating cash generation disrupted by large one-time liability settlements, and the balance sheet reflects sharply rising leverage offset by removal of a major contingent liability.

Composite Trajectory: Mixed

Revenue and gross margin are improving on both annual and quarterly bases (FY2025 revenue $7,472M up 10.5% YoY, gross margin 29.4% vs 28.1%; Q2 2026 revenue $1,981M up 2.0% YoY, gross margin 30.0% vs 29.3%). However, operating income is declining in 2026 quarters (Q2 2026 $131M vs $177M YoY, margin 6.6% vs 9.1%) due to higher SG&A, restructuring, and spin-off costs. Operating cash flow turned deeply negative in FY2025 ($(1,137M) vs $444M) and remained near zero YTD 2026 ($3M vs $135M) driven by the $1,590M Indemnification Agreement termination payment and working capital outflows. Total debt rose 60% in FY2025 to $3,231M and increased further to $3,622M gross by July 2026, though the Indemnification liability ($723M at Jan 2025) was eliminated. Equity fell in FY2025 ($2,917M vs $3,309M) but recovered partially YTD 2026 ($3,006M).

2. Red Flags

• Operating cash flow negative in FY2025 ($(1,137M)) and minimal in YTD 2026 ($3M) despite revenue growth (10-K FY2025, Consolidated Statements of Cash Flows; 10-Q Q2 2026, Cash Flow Summary)
• Operating income margin compression in 2026 quarters: Q2 2026 6.6% vs Q2 2025 9.1%; YTD 2026 6.0% vs YTD 2025 8.4% (10-Q Q2 2026, Consolidated Statements of Operations)
• Total debt increased 60% in FY2025 to $3,231M from $2,015M, and rose further to $3,622M gross by July 2026 (10-K FY2025, Note 11; 10-Q Q2 2026, Liquidity and Capital Resources)
• Interest expense nearly doubled: FY2025 $135M vs FY2024 $81M; YTD 2026 $93M vs YTD 2025 $49M (10-K FY2025, Consolidated Statements of Operations; 10-Q Q2 2026, Consolidated Statements of Operations)
• Restructuring expenses jumped to $28M YTD 2026 from $6M YTD 2025; business separation costs $55M YTD 2026 (10-Q Q2 2026, MD&A)
• $1,590M one-time Indemnification termination payment funded primarily by $1,225M incremental term loans (10-K FY2025, MD&A Liquidity; Note 11)

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Revenue grew 10.5% annually to $7,472M (FY2025 vs FY2024) and 2.0% in Q2 2026 to $1,981M (vs Q2 2025). Gross margin expanded 130 bps annually to 29.4% and 70 bps in Q2 2026 to 30.0%. However, operating income fell 26% in Q2 2026 to $131M (margin 6.6%) from $177M (9.1%) YoY, and declined 26% YTD to $233M (6.0%) from $313M (8.4%), driven by higher SG&A ($332M vs $319M Q2), restructuring ($22M vs $2M Q2), and business separation costs ($31M Q2). Net income swung to $97M in Q2 2026 from $(825M) in Q2 2025, but the comparison is distorted by the absence of $882M Indemnification expense in 2026 and a $77M Tax Matters Agreement settlement benefit. Interest expense rose sharply due to higher debt ($46M Q2 2026 vs $24M Q2 2025).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Deteriorating

Operating cash flow collapsed to $(1,137M) in FY2025 from $444M in FY2024, primarily due to the $1,590M Indemnification termination payment (reflected as $583M reduction in non-current obligations payable and $111M greater use in accrued liabilities). YTD 2026 operating cash flow was only $3M vs $135M YTD 2025, with a $1,146M unfavorable working capital change including $902M Indemnification liability termination, $123M cash paid for accrued liabilities, $64M receivables increase, and $49M inventory build. Investing cash outflows moderated to $(55M) YTD 2026 from $(51M) YTD 2025. Financing inflows surged to $342M YTD 2026 from $(33M) YTD 2025, driven by $400M Senior Notes due 2034 proceeds (restricted for ADIG). Free cash flow is not explicitly reported.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Total debt rose from $2,015M (Dec 2024) to $3,231M (Dec 2025) to $3,622M gross (July 2026), with the $400M 7.125% Senior Notes due 2034 earmarked for ADIG. The Indemnification Agreement liability ($723M at Jan 2025) was fully eliminated by Dec 2025. Cash declined to $549M (July 2026) from $661M (Dec 2025), while restricted cash of $400M appeared for the ADIG notes. Receivables grew to $1,214M from $1,073M and inventory to $1,392M from $1,354M over the same period. Total equity fell to $2,917M (Dec 2025) from $3,309M (Dec 2024) due to the FY2025 net loss of $(527M), then recovered to $3,006M (July 2026) on YTD net income of $135M. Goodwill and intangibles declined modestly with amortization.

6. Data Gaps

• Full FY2026 results (only six months ended July 4, 2026 available)
• Post-ADI Spin-Off standalone Resideo financials (spin-off completed August 3, 2026, after reporting period)
• Quarterly cash flow statements for Q1 2026 and Q3/Q4 2025 (only YTD and FY provided)
• Segment-level cash flow generation (not disclosed)
• Detailed debt maturity schedule beyond aggregate principal payments shown in 10-K Note 11
• Quantified impact of ADI Spin-Off on Resideo's pro forma leverage, interest expense, and cash flows
• Free cash flow metric (not explicitly reported)